# onconova.fhir#0.1.0: Onconova Implementation Guide

## Pages

* [Home](index.md)
* [Artifacts Summary](artifacts.md)

## Resources

### CodeSystems

* [Comorbidity Panels Code System](CodeSystem-onconova-cs-comorbidity-panels.md)
* [To Be Determined Codes](CodeSystem-onconova-cs-tbd.md)

### ValueSets

* [TNM Lymphatic Invasion Categories Value Set](ValueSet-onconova-tnm-lymphatic-invasion-categories.md)
* [TNM Perineural Invasion Categories Value Set](ValueSet-onconova-tnm-perineural-invasion-categories.md)
* [TNM Residual Tumor Categories Value Set](ValueSet-onconova-tnm-residual-tumor-categories.md)
* [Adjunctive Therapy Roles](ValueSet-onconova-vs-adjunctive-therapy-roles.md)
* [Adverse Event Mitigation Categories](ValueSet-onconova-vs-adverse-event-mitigation-categories.md)
* [Adverse Event Mitigation - Drugs](ValueSet-onconova-vs-adverse-event-mitigation-drugs.md)
* [Adverse Event Mitigation - Management](ValueSet-onconova-vs-adverse-event-mitigation-managements.md)
* [Adverse Event Mitigation - Procedures](ValueSet-onconova-vs-adverse-event-mitigation-procedures.md)
* [Adverse Event Mitigation - Treatment Adjustment](ValueSet-onconova-vs-adverse-event-mitigation-treatment-adjustments.md)
* [Antineoplastic Agents](ValueSet-onconova-vs-antineoplastic-agents.md)
* [Cancer Imaging Methods](ValueSet-onconova-vs-cancer-imaging-methods.md)
* [Cancer Risk Assessment Methods](ValueSet-onconova-vs-cancer-risk-assessment-methods.md)
* [Risk Assessment Values](ValueSet-onconova-vs-cancer-risk-assessment-values.md)
* [Cause of Death Value Set](ValueSet-onconova-vs-causes-of-death.md)
* [Comorbidity Panels](ValueSet-onconova-vs-comorbidity-panels.md)
* [CTC Adverse Events](ValueSet-onconova-vs-ctc-adverse-events.md)
* [Expected Drug Effects](ValueSet-onconova-vs-expected-drug-effects.md)
* [Exposure Agents](ValueSet-onconova-vs-exposure-agents.md)
* [ICD-10 Codes](ValueSet-onconova-vs-icd-10-conditions.md)
* [ICD-O-3 Morphology Behavior](ValueSet-onconova-vs-icdo3-morphology-behavior.md)
* [ICD-O-3 Topography](ValueSet-onconova-vs-icdo3-topography.md)
* [Observation Body Sites Value Set](ValueSet-onconova-vs-observation-bodysites.md)
* [Recreational Drugs](ValueSet-onconova-vs-recreational-drugs.md)
* [Smoking status](ValueSet-onconova-vs-smoking-status.md)
* [TNM Distant Metastasis Categories Value Set](ValueSet-onconova-vs-tnm-distant-metastasis-categories.md)
* [TNM Grade Categories Value Set](ValueSet-onconova-vs-tnm-grade-categories.md)
* [TNM Grade Category Methods Value Set](ValueSet-onconova-vs-tnm-grade-category-methods.md)
* [TNM Primary Tumor Categories](ValueSet-onconova-vs-tnm-primary-tumor-categories.md)
* [TNM Regional Nodes Categories Value Set](ValueSet-onconova-vs-tnm-regional-nodes-categories.md)
* [TNM Serum Tumor Marker Level Categories Value Set](ValueSet-onconova-vs-tnm-serum-tumor-marker-level-categories.md)
* [TNM Venous Invasion Categories Value Set](ValueSet-onconova-vs-tnm-venous-invasion-categories.md)
* [Treatment Termination Reasons](ValueSet-onconova-vs-treatment-termination-reasons.md)
* [Tumor Board Recommendations](ValueSet-onconova-vs-tumor-board-recommendations.md)
* [Tumor Marker Analytes](ValueSet-onconova-vs-tumor-marker-analytes.md)

### Resource Profiles

* [Karnofsky Performance Status Profile](StructureDefinition-onconova-Karnofsky-performance-status.md)
* [Adverse Event Profile](StructureDefinition-onconova-adverse-event.md)
* [Aneuploid Score Profile](StructureDefinition-onconova-aneuploid-score.md)
* [Cancer Family Member History](StructureDefinition-onconova-cancer-family-member-history.md)
* [Cancer Patient Profile](StructureDefinition-onconova-cancer-patient.md)
* [Cancer Risk Assessment Profile](StructureDefinition-onconova-cancer-risk-assessment.md)
* [Cancer Stage](StructureDefinition-onconova-cancer-stage.md)
* [Comorbidities Profile](StructureDefinition-onconova-comorbidities.md)
* [ECOG Performance Status Profile](StructureDefinition-onconova-ecog-performance-status.md)
* [Genomic Variant Profile](StructureDefinition-onconova-genomic-variant.md)
* [Homologous Recombination Deficiency Profile](StructureDefinition-onconova-homologous-recombination-deficiency.md)
* [Imaging Disease Status Profile](StructureDefinition-onconova-imaging-disease-status.md)
* [Lifestyle Profile](StructureDefinition-onconova-lifestyle.md)
* [Loss of Heterozygosity Profile](StructureDefinition-onconova-loss-of-heterozygosity.md)
* [Medication Administration Profile](StructureDefinition-onconova-medication-administration.md)
* [Microsatellite Instability Profile](StructureDefinition-onconova-microsatellite-instability.md)
* [Molecular Tumor Board Review](StructureDefinition-onconova-molecular-tumor-board-review.md)
* [Primary Cancer Condition Profile](StructureDefinition-onconova-primary-cancer-condition.md)
* [Radiotherapy Summary Profile](StructureDefinition-onconova-radiotherapy-summary.md)
* [Secondary Cancer Condition Profile](StructureDefinition-onconova-secondary-cancer-condition.md)
* [Serum Tumor Marker Level Category](StructureDefinition-onconova-serous-tumor-marker-level-category.md)
* [Surgical Procedure Profile](StructureDefinition-onconova-surgical-procedure.md)
* [Therapy Line Profile](StructureDefinition-onconova-therapy-line.md)
* [TNM Distant Metastases Category](StructureDefinition-onconova-tnm-distant-metastases-category.md)
* [TNM Grade Category](StructureDefinition-onconova-tnm-grade-category.md)
* [TNM Lymphatic Invasion Category](StructureDefinition-onconova-tnm-lymphatic-invasion-category.md)
* [TNM Perineural Invasion Category](StructureDefinition-onconova-tnm-perineural-invasion-category.md)
* [TNM Primary Tumor Category](StructureDefinition-onconova-tnm-primary-tumor-category.md)
* [TNM Regional Nodes Category](StructureDefinition-onconova-tnm-regional-nodes-category.md)
* [TNM Residual Tumor Category](StructureDefinition-onconova-tnm-residual-tumor-category.md)
* [TNM Stage Group](StructureDefinition-onconova-tnm-stage-group.md)
* [Tumor Board Review](StructureDefinition-onconova-tumor-board-review.md)
* [Tumor Marker Profile](StructureDefinition-onconova-tumor-marker.md)
* [Tumor Mutational Burden Profile](StructureDefinition-onconova-tumor-mutational-burden.md)
* [Tumor Neoantigen Burden Profile](StructureDefinition-onconova-tumor-neoantigen-burden.md)
* [Venous Invasion Category](StructureDefinition-onconova-venous-invasion-category.md)

### Extensions

* [Therapy Line Reference](StructureDefinition-ext-therapy-line-reference.md)
* [Adjunctive Role](StructureDefinition-onconova-ext-adjunctive-role.md)
* [Adverse Event Mitigation](StructureDefinition-onconova-ext-adverse-event-mitigation.md)
* [Age at Diagnosis](StructureDefinition-onconova-ext-age-at-diagnosis.md)
* [Age](StructureDefinition-onconova-ext-age.md)
* [Anonymized Entry](StructureDefinition-onconova-ext-anonymized-entry.md)
* [Cancer Morphology](StructureDefinition-onconova-ext-cancer-morphology.md)
* [Cancer Topography](StructureDefinition-onconova-ext-cancer-topography.md)
* [Cause of Death](StructureDefinition-onconova-ext-cause-of-death.md)
* [Combined With](StructureDefinition-onconova-ext-combined-with.md)
* [Contributors](StructureDefinition-onconova-ext-contributors.md)
* [CTCAE Grade](StructureDefinition-onconova-ext-ctc-grade.md)
* [Cycles](StructureDefinition-onconova-ext-cycles.md)
* [Data Completion Rate](StructureDefinition-onconova-ext-data-completion-rate.md)
* [End of Records](StructureDefinition-onconova-ext-end-of-records.md)
* [Is Primary Therapy](StructureDefinition-onconova-ext-is-primary-therapy.md)
* [Molecular Tumor Board CUP Characterization](StructureDefinition-onconova-ext-molecular-tumor-board-cup-characterization.md)
* [Molecular Tumor Board Molecular Comparison](StructureDefinition-onconova-ext-molecular-tumor-board-molecular-comparison.md)
* [Molecular Tumor Board Therapeutic Recommendation](StructureDefinition-onconova-ext-molecular-tumor-board-therapeutic-recommendation.md)
* [Overall Survival](StructureDefinition-onconova-ext-overall-survival.md)
* [Recist Is Interpreted](StructureDefinition-onconova-ext-recist-is-interpreted.md)
* [Recurrence Of](StructureDefinition-onconova-ext-recurrence-of.md)
* [Risk Assessment Score](StructureDefinition-onconova-ext-risk-assessment-score.md)
* [Therapy Line Intent](StructureDefinition-onconova-ext-therapy-line-intent.md)
* [Therapy Line Number](StructureDefinition-onconova-ext-therapy-line-number.md)
* [Therapy Line Period](StructureDefinition-onconova-ext-therapy-line-period.md)
* [Therapy Line Progression Date](StructureDefinition-onconova-ext-therapy-line-progression-date.md)
* [Therapy Line Progression-Free Survival](StructureDefinition-onconova-ext-therapy-line-progression-free-survival.md)
* [Tumor Board Specialization](StructureDefinition-onconova-ext-tumor-board-specialization.md)
* [Tumor Marker Analyte](StructureDefinition-onconova-ext-tumor-marker-analyte.md)
* [Unknown Entry](StructureDefinition-onconova-ext-unknown-entry.md)

### CapabilityStatements

* [Onconova FHIR REST Capability Statement](CapabilityStatement-onconova-capability-statement.md)

### ImplementationGuides

* [Onconova Implementation Guide](index.md)
